Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

From the Editors

Posted on 18 March 2014 |

MK-0616 - How near is an oral PCSK9i?

John chapman & Chris PackardProfessors John Chapman and Chris Packard consider the evidence supporting MK-0616 as potentially the first oral PCSK9i to reach the clinic.

Read the editorial

Related reports:

Phase 2b data show benefits of oral MK-0616 in hypercholesterolaemia

MK-0616: Hope for an oral PCSK9 inhibitor?

Related content